IP Library Granted Patent US 8,058,411
Granted Patent B2
US 8,058,411 · App. 12/152,762 · Granted Nov 15, 2011

Method for producing mature VWF from VWF pro-peptide

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,058,411
App. No.
12/152,762
Granted
Nov 15, 2011
Kind
B2
Abstract

The present invention relates to a method for producing a mature von Willebrand Factor (VWF) from von Willebrand Factor pro-peptide comprising the steps: immobilizing VWF pro-peptide on an ion exchange resin, incubating the immobilized VWF pro-peptide with furin to obtain immobilized mature VWF, and isolating mature VWF from the ion exchange resin by elution.

Claims (33)

1. A method for producing mature von Willebrand Factor (VWF) from von Willebrand Factor pro-peptide comprising the steps of:

(a) immobilizing VWF pro-peptide on an ion exchange resin,

(b) incubating the immobilized VWF pro-peptide with furin comprising activity of at least 0.2 Units furin/Unit VWF antigen (Ag) to obtain immobilized mature VWF, and

(c) isolating at least 90% mature VWF from the ion exchange resin by elution.

2. The method according to claim 1 , wherein said VWF pro-peptide is of recombinant origin.

3. The method according to claim 1 , wherein said ion exchange resin comprises trimethylaminoethyl-groups (TMAE).

4. The method according to claim 1 , wherein said ion exchange resin is packed in a chromatographic column.

5. The method according to claim 3 , wherein said VWF pro-peptide is immobilized on the ion exchange resin and incubated with furin at a conductivity measured at 25° C. below 25 mS/cm.

6. The method according to claim 5 , wherein said conductivity is below 20 mS/cm.

7. The method according to claim 5 , wherein said conductivity is below 16 mS/cm.

8. The method according to claim 3 , wherein said mature VWF is eluted from the ion exchange resin at a conductivity measured at 25° C. of at least 40 mS/cm.

9. The method according to claim 8 wherein said conductivity is at least 60 mS/cm.

10. The method according to claim 8 wherein said conductivity is at least 80 mS/cm.

11. The method according to claim 1 , wherein said furin is comprised in a solution, which comprises further CaCl 2 at a concentration of 0.01 to 10 mM.

12. The method according to claim 11 , wherein said CaCl 2 is at a concentration of 0.1 to 5 mM.

13. The method according to claim 11 , wherein said CaCl 2 is at a concentration of 0.2 to 2 mM.

14. The method according to claim 1 , wherein the incubation is performed for 1 min to 48 hours.

15. The method according to claim 14 , wherein said incubation is performed for 10 min to 42 hours.

16. The method according to claim 15 , wherein said incubation is performed for 20 min to 36 hours.

17. The method according to claim 16 , wherein said incubation is performed for 30 min to 24 hours.

18. The method according to claim 1 , wherein the incubation is performed at a temperature of 2 to 40° C.

19. The method according to claim 18 , wherein said incubation is performed at a temperature of 4 to 37° C.

20. The method according to claim 1 , wherein said furin is of recombinant origin.

21. The method according to claim 1 wherein the furin comprises activity of at least 0.5 Units furin/Unit VWF Ag.

22. The method according to claim 21 wherein the furin comprises activity between 0.5-4.0 Units furin/Unit VWF Ag.

23. The method according to claim 21 wherein mature VWF is at least 95% mature VWF.

24. The method according to claim 21 wherein mature VWF is at least 98% mature VWF.

25. The method according to claim 21 wherein mature VWF is at least 99% mature VWF.

26. The method according to claim 22 wherein incubating is carried out for at least 1 hour.

27. The method according to claim 26 wherein incubating is carried out at 2° C. to 8° C.

28. The method according to claim 26 wherein incubating is carried out at 37° C.

29. The method according to claim 24 wherein a mean of 0.9 Units furin/Unit VWF Ag is incubated for at least 4 hours.

30. The method according to claim 1 wherein the furin comprises activity between 0.2 to 2.0 Units furin/Unit VWF Ag for 4 hours.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 31, 2021
From: BAXALTA GMBH; BAXALTA INCORPORATED
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 055189/0005 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 17, 2015
From: BAXTER HEALTHCARE SA
To: BAXALTA GMBH; BAXALTA INCORPORATED
Reel/Frame 036362/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 17, 2015
From: BAXTER INTERNATIONAL INC.
To: BAXALTA GMBH; BAXALTA INCORPORATED
Reel/Frame 036374/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 21, 2008
From: MUNDT, WOLFGANG; MITTERER, ARTUR; HASSLACHER, MEINHARD; MAYER, CHRISTA
To: BAXTER INTERNATIONAL INC.; BAXTER HEALTHCARE S A
Reel/Frame 021424/0687 →